Sun Pharma slips 7% after opening 2% up

In a regulatory filing, Sun Pharma said "the settlements extend to all claims brought by the Direct Purchaser Plaintiffs".

from Stocks-Markets-Economic Times https://ift.tt/2P4c4xz